Is Myomo, Inc. (MYO) a Buy, Sell, or Hold?
AMEX : MYO
Myomo, Inc.
$1.375 USD
$0.07 (4.96%)
- Volume
- 763.09K
- Average Volume
- 760.16K
- Market Capitalization
- $53.13M
- P/E Ratio
- -4.04
- Dividend Yield
- 0.00%
- Price Target
- $1.10
- Year High
- $1.99
- Year Low
- $0.61
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.31
Company Overview
AMEX
Paul R. Gudonis
Medical - Devices
Healthcare
MYO
195
US
USD
Liquidity Metrics
3.44
2.31
2.01
1.06
0.00
Sales & Valuation
$40.93M
1.23
10.07
-6.01
-0.21
Profitability
-$0.37
-$15.57M
-33.53%
-32.52%
-142.02%
-41.05%
P/E Metrics
-4.04
0.10
0.10
Analyst Price Target & Rating
$1.10
$1.10
$1.10
2/5
8 Analysts
25.00%
Financial Health Scores
-3.40
2/9
$13.92M
$35.34M
$29.51M
-$12.28M
Key Metrics (TTM)
$59.48M
1.37
-5.22
2.31
-142.02%
-45.17%
-25.94%
-17.45%
-74 days
Company Executives
| Name | Title |
|---|---|
| Micah J. Mitchell | Chief Commercial Officer |
| Malcolm G. Bock | Vice President of Engineering & Product Strategy |
| Galina Shtivelman | Senior Director of Human Resources |
| Kathy Sawyers | Sr. Director of Clinical Outcomes |
| David A. Henry | Chief Financial Officer |
| Colin Anderson | Global Director of Operations |
| Harry Kovelman | Chief Medical Officer |
| Paul R. Gudonis | President, Chief Executive Officer & Chairman |
Poll Results
No votes yet today — be the first to share your view!
About Myomo, Inc. (AMEX:MYO) Stock
Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury, traumatic brain injury, and brachial plexus injuries. Myomo distributes its innovative solutions through a network that includes orthotics and prosthetics providers, rehabilitation hospitals, the Veterans Hea ... lth Administration, and additional distributors. Established in 2004, Myomo, Inc. maintains its corporate headquarters in Boston, Massachusetts.
Myomo, Inc. (MYO) Q2 2026 Earnings Call Transcript
2026-08-05 23:10:03
Myomo, Inc. (MYO) Q2 2026 Earnings Call Transcript
Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates
2026-08-05 21:36:53
Myomo, Inc. (MYO) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.11 per share a year ago.
Myomo Reports Second Quarter 2026 Financial and Operating Results
2026-08-05 16:05:00
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO)(“Myomo” or the “Company”), a wearable medical robotics platform company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three and six months ended June 30, 2026. “I am pleased to report that the evolution of our go-to-market approach is driving positive results. Revenue of $11.7 million exceeded our expectations, with 53% of.
Myomo to Report Second Quarter 2026 Financial Results on August 5
2026-07-29 16:05:00
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the second quarter ended June 30, 2026 on Wednesday, August 5, 2026. Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide a business update and an.
2026-06-23 16:12:11
Myomo, Inc. (MYO) Presents at IAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 Transcript
Myomo Announces Participation in iAccess Alpha Virtual Best Ideas Summer Investment Conference
2026-06-16 16:05:00
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced its participation in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026, taking place June 23–24, 2026. President and Chief Executive Officer Paul Gudonis and Chief Financial Officer David Henry will deliver a presentati.
Myomo (MYO) Shows Fast-paced Momentum But Is Still a Bargain Stock
2026-05-28 09:55:55
Myomo (MYO) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Myomo Appoints Joseph M. Manko to its Board of Directors
2026-05-13 16:05:00
BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Joseph M. (“Joe”) Manko Jr. as a director effective May 9, 2026, to serve until the 2027 annual meeting of stockholders. With this appointment, Myomo has seven directors. Mr. Manko is an accomplished investor with over 25.
Frequently Asked Questions
-
What is the current Myomo, Inc. (MYO) stock price?
-
Myomo, Inc.(AMEX:MYO) stock price is $1.375 in the last trading session. During the trading session, MYO stock reached the peak price of $1.985 while $0.605 was the lowest point it dropped to. The percentage change in MYO stock occurred in the recent session was 4.96% while the dollar amount for the price change in MYO stock was $0.07.
-
MYO's industry and sector of operation?
-
The AMEX listed MYO is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of MYO?
-
Micah J. Mitchell | Chief Commercial Officer
Malcolm G. Bock | Vice President of Engineering & Product Strategy
Galina Shtivelman | Senior Director of Human Resources
Kathy Sawyers | Sr. Director of Clinical Outcomes
David A. Henry | Chief Financial Officer -
How many employees does MYO have?
-
Number of MYO employees currently stands at 195. MYO operates from 45 Blue Sky Dr., Burlington, MA 01803, US.
-
Link for MYO official website?
-
Official Website of MYO is: https://www.myomo.com
-
How do I contact MYO?
-
MYO could be contacted at phone #617 996 9058 and can also be accessed through its website. MYO operates from 45 Blue Sky Dr., Burlington, MA 01803, US.
-
How many shares of MYO are traded daily?
-
The average number of MYO shares traded daily for last 3 months was 760.16K.
-
What is the market cap of MYO currently?
-
The market value of MYO currently stands at $53.13M with its latest stock price at $1.375